<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://mfrdinfo.com/ems1/index.php?action=history&amp;feed=atom&amp;title=Drug_Overdose_Poisoning</id>
	<title>Drug Overdose Poisoning - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://mfrdinfo.com/ems1/index.php?action=history&amp;feed=atom&amp;title=Drug_Overdose_Poisoning"/>
	<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Drug_Overdose_Poisoning&amp;action=history"/>
	<updated>2026-08-18T19:04:08Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.32.0</generator>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Drug_Overdose_Poisoning&amp;diff=27729&amp;oldid=prev</id>
		<title>Mfrdmanager at 13:47, 13 November 2020</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Drug_Overdose_Poisoning&amp;diff=27729&amp;oldid=prev"/>
		<updated>2020-11-13T13:47:52Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 13:47, 13 November 2020&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l6&quot; &gt;Line 6:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 6:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Obtain and record blood sugar level and refer to [[Hypo or Hyperglycemia|HYPO / HYPERGLYCEMIA PRACTICE PARAMETERS]] (5.10), as indicated.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Obtain and record blood sugar level and refer to [[Hypo or Hyperglycemia|HYPO / HYPERGLYCEMIA PRACTICE PARAMETERS]] (5.10), as indicated.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* If altered sensorium, refer to [[Altered Mental Status (AMS)|ALTERED MENTAL STATUS PRACTICE PARAMETER]] (5.03).&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* If altered sensorium, refer to [[Altered Mental Status (AMS)|ALTERED MENTAL STATUS PRACTICE PARAMETER]] (5.03).&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* IF CORROSIVE INGESTION, administer &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;an &lt;/del&gt;[[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Antiemetics&lt;/del&gt;|&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Antiemetic&lt;/del&gt;]] medication as appropriate.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* IF CORROSIVE INGESTION, administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Promethazine&lt;/ins&gt;|&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;PROMETHAZINE]] OR [[Zofran|ZOFRAN&lt;/ins&gt;]] medication as appropriate.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* For tricyclic and tetracyclic antidepressant overdose:&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* For tricyclic and tetracyclic antidepressant overdose:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** If wide complexes (QRS &amp;gt;0.10 sec), hypotension and any other arrhythmias, Administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Electrolytes&lt;/del&gt;|SODIUM BICARBONATE]], 1 meq/kg IVP. Repeat in 5 or 10 minutes.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** If wide complexes (QRS &amp;gt;0.10 sec), hypotension and any other arrhythmias, Administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Sodium Bicarbonate&lt;/ins&gt;|SODIUM BICARBONATE]], 1 meq/kg IVP. Repeat in 5 or 10 minutes.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** If Torsades de Pointes administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Electrolytes&lt;/del&gt;|MAGNESIUM SULFATE]] 2 gm, IV bolus (if no renal disease).&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** If Torsades de Pointes administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Magnesium Sulfate&lt;/ins&gt;|MAGNESIUM SULFATE]] 2 gm, IV bolus (if no renal disease).&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* For Antipsychotics and Acute Dystonic Reaction,&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* For Antipsychotics and Acute Dystonic Reaction,&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Antihistamines&lt;/del&gt;|DIPHENHYDRAMINE]] (BENADRYL) 25 mg IV bolus.  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Diphenhydramine&lt;/ins&gt;|DIPHENHYDRAMINE]] (BENADRYL) 25 mg IV bolus.  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** If there is an inadequate response, repeat in 10 minutes.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** If there is an inadequate response, repeat in 10 minutes.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* For Calcium Channel blockers,&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* For Calcium Channel blockers,&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**For patients with cardiovascular toxicity, as manifested by one or more of the following:  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**For patients with cardiovascular toxicity, as manifested by one or more of the following:  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;***Hemodynamically significant bradycardia or HB , including 3° HB and high grade 2° HB&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;***Hemodynamically significant bradycardia or HB , including 3° HB and high grade 2° HB&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**** Administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Antiarrhythmics&lt;/del&gt;|ATROPINE]] 0.5 mg IV, may repeat x 2 if no response.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**** Administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Atropine&lt;/ins&gt;|ATROPINE]] 0.5 mg IV, may repeat x 2 if no response.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**** If no response, [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Electrolytes&lt;/del&gt;|CALCIUM CHLORIDE]] 1 gm IV, If no response, repeat x 1&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**** If no response, [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Calcium Chloride&lt;/ins&gt;|CALCIUM CHLORIDE]] 1 gm IV, If no response, repeat x 1&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**** If no response, [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Antidiabetics&lt;/del&gt;|GLUCAGON]] 3 mg IV or IN, If no response, repeat x 1&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**** If no response, [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Glucagon&lt;/ins&gt;|GLUCAGON]] 3 mg IV or IN, If no response, repeat x 1&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**** If no response, begin [[Transcutaneous Pacing Procedure|TRANSCUTANEOUS PACING]] (TCP). (9.30)  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**** If no response, begin [[Transcutaneous Pacing Procedure|TRANSCUTANEOUS PACING]] (TCP). (9.30)  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;***If hypotension give 200 – 300 cc NS bolus, repeat as needed.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;***If hypotension give 200 – 300 cc NS bolus, repeat as needed.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**** Administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Electrolytes&lt;/del&gt;|CALCIUM CHLORIDE]] 1 gm IV, may repeat x 1.  Avoid if patient is on digoxin/lanoxin.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**** Administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Calcium Chloride&lt;/ins&gt;|CALCIUM CHLORIDE]] 1 gm IV, may repeat x 1.  Avoid if patient is on digoxin/lanoxin.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**** Administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Antidiabetics&lt;/del&gt;|GLUCAGON]] 2 mg IV or IN, may repeat x 1.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**** Administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Glucagon&lt;/ins&gt;|GLUCAGON]] 2 mg IV or IN, may repeat x 1.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* For Beta blockers:&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* For Beta blockers:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**For patients with cardiovascular toxicity, as manifested by one or more of the following:  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**For patients with cardiovascular toxicity, as manifested by one or more of the following:  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;***Hemodynamically significant bradycardia or HB, including 3° HB and high grade 2° HB  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;***Hemodynamically significant bradycardia or HB, including 3° HB and high grade 2° HB  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;****Administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Antiarrhythmics&lt;/del&gt;|ATROPINE]] 0.5 mg IV, may repeat x 2 if no response.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;****Administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Atropine&lt;/ins&gt;|ATROPINE]] 0.5 mg IV, may repeat x 2 if no response.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;****If no response, [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Antidiabetics&lt;/del&gt;|GLUCAGON]] 2 mg IV or IN, If no response, repeat x 1&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;****If no response, [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Glucagon&lt;/ins&gt;|GLUCAGON]] 2 mg IV or IN, If no response, repeat x 1&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;****If no response begin [[Transcutaneous Pacing Procedure|Transcutaneous Pacing]] (TCP) (9.30)&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;****If no response begin [[Transcutaneous Pacing Procedure|Transcutaneous Pacing]] (TCP) (9.30)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;***If hypotension&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;***If hypotension&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;****200 – 300 cc NS bolus, repeat as needed.  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;****200 – 300 cc NS bolus, repeat as needed.  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;****Administer [[&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Antidiabetics&lt;/del&gt;|GLUCAGON]] 2 mg IV or IN, may repeat x 1.  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;****Administer [[&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Glucagon&lt;/ins&gt;|GLUCAGON]] 2 mg IV or IN, may repeat x 1.  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;====Physician's Order: POISON CONTROL INFORMATION and subsequent treatment.====&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;====Physician's Order: POISON CONTROL INFORMATION and subsequent treatment.====&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Drug_Overdose_Poisoning&amp;diff=139&amp;oldid=prev</id>
		<title>Mfrdmanager: Protected &quot;Drug Overdose Poisoning&quot; ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Drug_Overdose_Poisoning&amp;diff=139&amp;oldid=prev"/>
		<updated>2018-02-10T14:23:12Z</updated>

		<summary type="html">&lt;p&gt;Protected &amp;quot;&lt;a href=&quot;/ems1/index.php?title=Drug_Overdose_Poisoning&quot; title=&quot;Drug Overdose Poisoning&quot;&gt;Drug Overdose Poisoning&lt;/a&gt;&amp;quot; ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 14:23, 10 February 2018&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-notice&quot; lang=&quot;en&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(No difference)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Drug_Overdose_Poisoning&amp;diff=138&amp;oldid=prev</id>
		<title>Mfrdmanager: Created page with &quot;== Section 5 -MEDICAL == === 5.05 DRUG OVERDOSE / POISONING  ===  INITIAL MEDICAL CARE (2.01) - Provide OXYGEN or assist ventilations a...&quot;</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Drug_Overdose_Poisoning&amp;diff=138&amp;oldid=prev"/>
		<updated>2018-02-10T14:23:02Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;== Section 5 -MEDICAL == === 5.05 DRUG OVERDOSE / POISONING  ===  &lt;a href=&quot;/ems1/index.php?title=Initial_Medical_Assessment_and_Care&quot; title=&quot;Initial Medical Assessment and Care&quot;&gt;INITIAL MEDICAL CARE&lt;/a&gt; (2.01) - Provide OXYGEN or assist ventilations a...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Section 5 -MEDICAL ==&lt;br /&gt;
=== 5.05 DRUG OVERDOSE / POISONING  ===&lt;br /&gt;
&lt;br /&gt;
[[Initial Medical Assessment and Care|INITIAL MEDICAL CARE]] (2.01) - Provide OXYGEN or assist ventilations as appropriate for patient condition.&lt;br /&gt;
* DRAW BLOOD TUBES (9.03), if available.&lt;br /&gt;
* Obtain and record blood sugar level and refer to [[Hypo or Hyperglycemia|HYPO / HYPERGLYCEMIA PRACTICE PARAMETERS]] (5.10), as indicated.&lt;br /&gt;
* If altered sensorium, refer to [[Altered Mental Status (AMS)|ALTERED MENTAL STATUS PRACTICE PARAMETER]] (5.03).&lt;br /&gt;
* IF CORROSIVE INGESTION, administer an [[Antiemetics|Antiemetic]] medication as appropriate.&lt;br /&gt;
* For tricyclic and tetracyclic antidepressant overdose:&lt;br /&gt;
** If wide complexes (QRS &amp;gt;0.10 sec), hypotension and any other arrhythmias, Administer [[Electrolytes|SODIUM BICARBONATE]], 1 meq/kg IVP. Repeat in 5 or 10 minutes.&lt;br /&gt;
** If Torsades de Pointes administer [[Electrolytes|MAGNESIUM SULFATE]] 2 gm, IV bolus (if no renal disease).&lt;br /&gt;
* For Antipsychotics and Acute Dystonic Reaction,&lt;br /&gt;
** Administer [[Antihistamines|DIPHENHYDRAMINE]] (BENADRYL) 25 mg IV bolus. &lt;br /&gt;
** If there is an inadequate response, repeat in 10 minutes.&lt;br /&gt;
* For Calcium Channel blockers,&lt;br /&gt;
**For patients with cardiovascular toxicity, as manifested by one or more of the following: &lt;br /&gt;
***Hemodynamically significant bradycardia or HB , including 3° HB and high grade 2° HB&lt;br /&gt;
**** Administer [[Antiarrhythmics|ATROPINE]] 0.5 mg IV, may repeat x 2 if no response.&lt;br /&gt;
**** If no response, [[Electrolytes|CALCIUM CHLORIDE]] 1 gm IV, If no response, repeat x 1&lt;br /&gt;
**** If no response, [[Antidiabetics|GLUCAGON]] 3 mg IV or IN, If no response, repeat x 1&lt;br /&gt;
**** If no response, begin [[Transcutaneous Pacing Procedure|TRANSCUTANEOUS PACING]] (TCP). (9.30) &lt;br /&gt;
***If hypotension give 200 – 300 cc NS bolus, repeat as needed.&lt;br /&gt;
**** Administer [[Electrolytes|CALCIUM CHLORIDE]] 1 gm IV, may repeat x 1.  Avoid if patient is on digoxin/lanoxin.&lt;br /&gt;
**** Administer [[Antidiabetics|GLUCAGON]] 2 mg IV or IN, may repeat x 1.&lt;br /&gt;
* For Beta blockers:&lt;br /&gt;
**For patients with cardiovascular toxicity, as manifested by one or more of the following: &lt;br /&gt;
***Hemodynamically significant bradycardia or HB, including 3° HB and high grade 2° HB &lt;br /&gt;
****Administer [[Antiarrhythmics|ATROPINE]] 0.5 mg IV, may repeat x 2 if no response.&lt;br /&gt;
****If no response, [[Antidiabetics|GLUCAGON]] 2 mg IV or IN, If no response, repeat x 1&lt;br /&gt;
****If no response begin [[Transcutaneous Pacing Procedure|Transcutaneous Pacing]] (TCP) (9.30)&lt;br /&gt;
***If hypotension&lt;br /&gt;
****200 – 300 cc NS bolus, repeat as needed. &lt;br /&gt;
****Administer [[Antidiabetics|GLUCAGON]] 2 mg IV or IN, may repeat x 1. &lt;br /&gt;
&lt;br /&gt;
====Physician's Order: POISON CONTROL INFORMATION and subsequent treatment.====&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category:Medical|0505]]&lt;/div&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
</feed>